Plasma exchange for severe optic neuritis: treatment of 10 patients.
Ruprecht
K
K
Clinical Research Unit for Multiple Sclerosis and Neuroimmunology, Julius-Maximilians University, Josef-Schneider Str. 11, 97080 Würzburg, Germany. klemens.ruprecht@mail.uni-wuerzburg.de
Klinker
E
E
Dintelmann
T
T
Rieckmann
P
P
Gold
R
R
D000328:Adult; D003131:Combined Modality Therapy; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications; D009902:Optic Neuritis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D010951:Plasma Exchange; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a